All Updates

All Updates

icon
Filter
Partnerships
MiLaboratories partners with Miltenyi Biotec to advance next-generation therapies
Precision Medicine
Apr 29, 2024
This week:
Funding
Matr Foods raises EUR 20 million in debt funding to build mycelium meat factory
Plant-based Meat
Today
Last week:
M&A
Platform Science to acquire Trimble's global transportation telematics business units
Truck Industry Tech
Yesterday
Funding
Whatfix raises USD 100 million in Series E funding to expand business
EdTech: Corporate Learning
Yesterday
Product updates
Sky Mavis launches cross-game onboarding solution
Web3 Ecosystem
Sep 14, 2024
Funding
Bicara Therapeutics raises USD 315 million in IPO; plans to develop lead candidate ficerafusp alfa
Precision Medicine
Sep 13, 2024
Partnerships
Massive Bio and Foundation Medicine partner to improve cancer clinical trial enrollment
Precision Medicine
Sep 13, 2024
Partnerships
Moffitt Cancer Center partners with AstraZeneca to advance oncology cell therapies
Cell & Gene Therapy
Sep 13, 2024
Product updates
Quandela launches European quantum computer in North America
Quantum Computing
Sep 13, 2024
Partnerships
IonQ achieves high qubit gate fidelity on barium development platform
Quantum Computing
Sep 13, 2024
Partnerships
Massive Bio and Foundation Medicine partner to improve cancer clinical trial enrollment
Clinical Trial Technology
Sep 13, 2024
Precision Medicine

Precision Medicine

Apr 29, 2024

MiLaboratories partners with Miltenyi Biotec to advance next-generation therapies

Partnerships

  • MiLaboratories has teamed up with biotech firm Miltenyi Biotec to combine MiLaboratories' RNA kit technology for immune sequencing with Miltenyi Biotec's production and commercialization capabilities to advance the creation and use of next-generation treatments.

  • MiLaboratories will provide its RNA kits' immune sequencing technology to Miltenyi Biotec as part of this collaboration. Miltenyi Biotec aims to distribute these RNA kits widely, and it is supported by its extensive global reach. Additionally, it will incorporate MiLaboratories’ software solutions, MiXCR and Platforma, into its product offerings to enhance research capabilities and efficiency. The alliance is anticipated to spur innovation and progress in genomics, offering advanced tools to researchers and clinicians globally.

  • MiLaboratories is a biotech company specializing in developing proprietary software designed to map and understand the human immune system at a DNA level. Its flagship product, MiXCR, is a software suite used for the analysis of immunology sequencing data.

Contact us

Gain access to all industry hubs, market maps, research tools, and more
Get a demo
arrow
menuarrow

By using this site, you agree to allow SPEEDA Edge and our partners to use cookies for analytics and personalization. Visit our privacy policy for more information about our data collection practices.